Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mepivacaine versus bupivacaine for single-injection peribulbar anesthesia in cataract surgery
PACTR201810828658359Not yet recruiting
- Sponsor
- ashraf nabil
- Start
- Oct 2018
- Modality
- Small Molecules, Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Trial of mepivacaine, bupivacaine, lidocaine and hyaluronidase in cataract (2 arms), sponsored by ashraf nabil. Primary endpoints: Effectiveness and safety of percutaneous single-injection peribulbar technique and Orbital muscle akinesia. Planned start Oct 2018; status: not yet recruiting.
02
Drugs
mepivacainebupivacainelidocainehyaluronidase
03
Conditions
cataract
Beyond the preview
Go deeper on PACTR201810828658359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201810828658359.